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Abstract Objective: The most common urinary stones (calcium salts, uric acid)
form due to genetic factors and lifestyle. This review describes why, if and how med-
ication and lifestyle changes can reduce the risk of formation.
Methods: Previous reports were reviewed to obtain information on three aspects
of urolithiasis, i.e. epidemiology, mechanisms linking lifestyle and urolithiasis and
lifestyle intervention for preventing urolithiasis.
Results: Epidemiological evidence links the prevalence of urinary stone formation
to general lifestyle factors. Detailed analysis has identiﬁed individual lifestyle ele-
ments that affect the risk of urinary stone formation. Currently there are several con-
cepts that explain the mechanism of stone formation. Urinary markers like calcium,
oxalate, phosphate, uric acid and urinary pH are involved in all these concepts. Many
studies show that changing (combinations of) speciﬁc lifestyle elements has a favour-
able effect on these urinary markers. Based on this evidence, protocols have been
developed that use a combination of these lifestyle changes and medication to prevent
stone formation. In well-controlled studies where patients are optimally informed and
continuously motivated, these protocols clearly reduce the stone formation rate. In
general practice the result is less clear, because the time and tools are insufﬁcient to
maintain long-term patient compliance in the use of medication and lifestyle advice.
Conclusion: The risk of stone formation can be reduced in general practice when
the patient’s compliance is optimised by providing individualised advice, continuous
information, and feedback and incorporation of the advice into a regular lifestyle.
The use of ‘e-tools’ might enable this without increasing the time required from the
physician.
ª 2012 Arab Association of Urology. Production and hosting by Elsevier B.V.
All rights reserved.
Introduction
Most urinary stones formed in patients worldwide con-
tain calcium oxalates, calcium phosphates, uric acid or
urates, and form due to genetic factors and lifestyle.
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This review describes why, if and how medication and
lifestyle factors can reduce the risk of forming stones.
Further sections provide epidemiological evidence of
links between lifestyle and urinary stone formation, spe-
ciﬁc lifestyle elements that affect urinary stone forma-
tion and its urinary markers, the cascade of lifestyle
elements, urinary composition, and stone formation, a
protocol for the preventive treatment of stones that is
based on the consented protocol used in Germany [1],
and ﬁnally a discussion of why such protocols reduce
stone formation much less in general practice than in re-
search settings. The main reason for the latter is that pa-
tient compliance with long-term use of medication and
lifestyle advice is low, and the key elements for success
are continuous access to practical advice, efforts to
maintain patient’s motivation, continuous feedback
and incorporation of the advice into regular lifestyle.
An in-depth discussion of compliance by stone formers
with treatment is provided elsewhere in this journal.
Lifestyle and prevalence of urinary tract stone disease
In a review published 40 years ago Prien [3] discussed
the prevalence of stone formation throughout the world
at that time and the changes in prevalence over time in
relation to lifestyle. In any population the ﬁrst form is
endemic bladder stone disease (lower urinary tract,
LUT) affecting mainly children. Speciﬁc changes in the
lifestyle of that population move the disease to upper
urinary tract (UUT) stone formation, affecting mainly
adults [3]. During this transformation the prevalence
ﬁrst declines and later increases again. Endemic LUT
stones contain mainly uric acid, urates and struvite [4].
In Thailand, calcium oxalate is also a major component
of LUT stones [5,6]; the background for this is low hy-
giene and malnutrition, and in Thailand the malnutri-
tion can be accompanied by endemic [7] renal tubular
acidosis. A monotonous diet where energy is derived
mainly from cereals and vegetables provides high doses
of purines that can be converted to uric acid and lead to
hyperuricosuria [4]. UTI with urease-producing bacteria
increases both urinary pH and ammonium concentra-
tion. This favours the precipitation of ammonium–mag-
nesium-phosphate (struvite) and calcium phosphates. In
combination with hyperuricosuria the product can be
ammonium urate. When the standard of living increases
in an area with endemic bladder stone disease the inci-
dence of bladder stone disease decreases. This has been
attributed to the more balanced diet, including more
dairy products and animal protein [8,9].
Whereas the change from a ‘primitive’ lifestyle to an
‘intermediate economic’ lifestyle [10] reduces the inci-
dence of overall stone formation, further changes in life-
style, towards the so-called western lifestyle, increases
the prevalence of urinary stone formation again, now
as UUT stones [10]. Well-balanced might be the
keyword here. Those vegetarians who succeed in main-
taining a well-balanced diet have a low risk of LUT
stone disease but also of UUT stone formation [11].
Periods of stone disease were apparent in European
countries and Japan between the First and Second
World Wars and after World War II [12,13]. In 1971,
the situation was one where UUT stones were most pre-
valent in the economically most-developed countries [3].
The stones contained calcium salts and affected mainly
men. In the decades thereafter endemic bladder stone
formation has further diminished throughout the world,
while the incidence of UUT stone formation increased
even further in western countries [14–16]. Again, lifestyle
changes appeared to cause this further increase. The
highest prevalence of UUT (71% calcium oxalate and
15% uric acid) stone disease has been reported for Arab
countries that combined a high economic standard with
a hot and dry climate, and local diet components high in
oxalate, e.g. 8–13% in Europe and USA vs. 18% in the
United Arab Emirates and 20% in Saudi Arabia [17].
Overall it appears that the working hypothesis formu-
lated by Andersen (Table 1) over half a century ago still
holds true, and that stone formers are best helped by the
advice to maintain a balanced diet and that can be
accompanied with medication. But what is a balanced
diet for stone formers?
Individual lifestyle elements and the risk of urinary tract
stone formation
To appreciate which lifestyle elements these could be, it
helps to understand the basic reasons for stone forma-
tion. Stones can only form when the urinary tract con-
tains higher concentrations of the stone-forming
material than can be kept in solution [18,19]. High con-
centrations of the mineral components in the urinary
tract thus pose a risk of stone formation. For UUT
stones the relevant components are calcium, oxalate,
phosphate and urate. These can derive from intrinsic
pools (calcium from bone or the non-ﬁlterable pool in
blood), from intrinsic production (uric acid, oxalate)
and from the diet (all components). Release from intrin-
sic pools and intrinsic production both can also be sub-
ject to dietary effects. When an attempt is made to
prevent stone formation both by medication and life-
style changes, the intrinsic production, the dietary con-
Table 1 Adaptation of the original working hypothesis, from
Andersen [10].
Economy
Primitive Intermediate Modern
Diet Unbalanced
deﬁcient
Balanced Unbalanced
overloaded
Stone risk
site
High, bladder Low High, UUT
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tent and the fraction of the dietary content that is actu-
ally taken up must be known. Furthermore, it must be
known whether dietary load ﬂuctuations during the
day cause ﬂuctuations in the risk of stone formation.
This is not a linear relationship. Super-saturation will
eventually lead to crystal formation but there is a time
lag. The mineralisation drive increases exponentially
with the super-saturation. Periods of the day where re-
cent events cause an extreme deviation of urinary com-
position thus pose the highest risk. The body might be
prepared for such mineralisation, as there is a mecha-
nism for renal crystal removal [20,21]. Possibly, stone
formation starts when this defence is overwhelmed,
but undoubtedly a reduction of the super-saturation
drive will be beneﬁcial.
Finally it must be acknowledged that the mineralisa-
tion drive depends not on total concentrations of stone
components but on their free concentrations plus the
solubility of the mineral in that urine. Here other life-
style elements come into play, those that determine urine
volume (water intake and sweat loss), complexation of
mineral components (magnesium and citrate), urinary
ionic strength (water/salt intake and sweat loss), urinary
pH (acid–base balance related to intake of protein and
organic acids). The effects of different individual life-
style elements are discussed ﬁrst in relation to the forma-
tion of calcium stones and then in relation to the
formation of uric acid/urate stones.
Medication and lifestyle advice for calcium-containing
stones
Calcium stones form when the urinary concentrations of
calcium, oxalate and phosphate are high enough and
(for calcium phosphate stones) urinary pH dictates the
correct ionic phosphate form.
Calcium, oxalate and phosphate content
Initially it would seem that a high dietary supply of cal-
cium, oxalate and phosphate all pose a risk of calcium-
salt stone formation. Hypercalciuria was the ﬁrst uri-
nary abnormality to be found in stone formers and at
present, next to a low urine volume, remains the most
common problem found in calcium-salt stone formers.
Next to the advice to drink more, the ﬁrst lifestyle advice
therefore was to reduce the intake of calcium. Unfortu-
nately a strict reduction of calcium intake caused bone
loss and did not reduce stone formation; it might actu-
ally have increased it. There are several explanations
for this. First, the glomerular ﬁltrate and thus the free
concentration of calcium in the serum dictate how much
calcium enters the nephron. This free calcium concentra-
tion is kept in a narrow range by regulation of intestinal
calcium uptake and renal calcium reabsorption. A high
dietary supply of calcium does not dramatically change
either the free serum concentration or the supply of
calcium at the glomerular level. It will down-regulate
the fractional intestinal uptake of calcium and reduce
reabsorption of calcium in the distal nephron parts.
Thus hypercalciuria based on dietary calcium intake
starts and increases the mineralisation drive only during
the short time that urine needs to pass these parts [22].
Hypercalciuria that is induced by a dietary acid load
(see below) or NaCl load, or by a disease associated with
hypercalcaemia, increases the mineralisation drive ear-
lier in the nephron [22]. The latter state also increases
that drive for the whole day, not only after meals.
For preventing hypercalciuria, the best advice to give
to calcium-salt stone formers is to maintain a normal
calcium intake, a low salt intake and to avoid a high die-
tary acid load. When hypercalciuria persists and intrin-
sic factors are suspected hydrochlorothiazide can be
prescribed. This medication has been shown to reduce
stone formation by correcting hypercalciuria at the cost
of moderate to severe side-effects [23].
By contrast, the dietary supply of oxalate plays a
more prominent role and oxalate restriction does reduce
the risk of stone formation. Part of the reason for this is
that the oxalate content of urine usually is about 10
times lower than the calcium content. An 0.1-mm
change in the urinary oxalate concentration has a 10
times greater effect on the calcium oxalate concentration
product (which drives crystal formation) than a 0.1-mm
increase in calcium concentration. The property of cal-
cium to bind oxalate drives crystal formation in the ur-
ine but also reduces the amount of oxalate available for
uptake in the intestine. When dietary calcium is re-
stricted, more oxalate is available for uptake. The body
compensates for the lower calcium supply by increasing
uptake efﬁciency. However, neither intestinal oxalate
uptake nor renal re-absorption is regulated. The extra
intestinal uptake causes an increase in urinary oxalate
that outweighs the decrease in urinary calcium. Epide-
miological studies have conﬁrmed this adverse effect of
a low dietary calcium intake [24]. The same mechanism
explains the increased urinary oxalate excretion and
stone risk after bariatric surgery, where the aim is to re-
duce the uptake of fatty acids [25]. The remaining fatty
acids bind calcium, which increases the free intestinal
oxalate concentration [26,27].
In general the advice is to reduce oxalate uptake. In a
few stone formers a genetic defect causes increased pro-
duction of oxalate, i.e. primary hyperoxaluria. In these
patients the effect of dietary oxalate restriction can be
insufﬁcient and they might need drugs. Pyridoxine aims
to correct the overproduction, but at the cost of side-ef-
fects. Correcting oxalate uptake can be achieved both
by restricting the intake of oxalate and by maintaining
a normal intake of calcium or by supplementation with
magnesium, which will also bind intestinal oxalate. How-
ever, magnesium supplementation should not be given in
the presence of renal insufﬁciency. There is a short list of
242 Kok
food items that contain much oxalate, mainly vegetables
and plant extracts like tea. In general it is not difﬁcult to
explain this list to the patient, and for the patient to avoid
their intake. However, speciﬁc cultural or individual pref-
erences can frustrate this. There is a second much longer
list of foods that contain less oxalate but still contribute
to the overall intake. It is very difﬁcult for patients to
monitor their total oxalate intake. Furthermore, it is a
problem for patients to assess how much oxalate was
bound by calcium andmagnesium in the intestine. To ob-
tain such insights, patients can rely on an Internet-based
dietary assessment which has become available in recent
years (e.g. www.niersteen.com).
Animal protein
While the addition of animal protein decreased the risk
of LUT stone formation, it became clear that further
addition to these levels in the so-called Western diet in-
creased the risk of UUT stone formation [28]. In men
with a normal body mass index (BMI) a high animal
protein intake is even an independent risk factor for cal-
cium-oxalate stone formation [29]. Conversely, when, in
a randomised prospective trial with recurrent hypercal-
ciuric calcium-oxalate stone formers, two characteristics
of that diet (excess intake of animal protein and of salt)
were reversed to normal values in addition to advice on
drinking, the relative risk of UUT stone formation de-
creased to 0.49, compared to the traditional low-calcium
diet [30]. This result might be exaggerated because the
low-calcium diet might by itself pose a risk. What this
effect would be compared to the Western-style diet can-
not be concluded. What sets this study apart from the
general situation is that the patients were examined dur-
ing a 3-month period, received semi-personalised dietary
advice, including intensive instruction on the effects of
the diet, and had regular guidance during the follow-
up. This high level of attention resulted in a withdrawal
rate of only 5%. Considering the changes in urinary
composition, compliance with all three aspects of advice
(drinking, low animal protein and low salt) was good
after 1 week. Adherence to the drinking advice stayed
high for the whole 5-year period. Adherence to low salt
and low protein intake decreased in the ﬁrst year and the
latter slightly deteriorated further over the following
4 years. By contrast, another study found no reduction
in stone recurrence when stone formers who already
had a normal intake of animal protein were advised to
make a further reduction [31]. The best advice appears
to be to avoid excess intake of animal protein and salt.
A closer examination of the mechanism that links high
animal protein intake to a high risk of stone formation
explains this.
Acid–base balance
A high animal-protein intake has three negative effects;
an increase in urinary calcium excretion, and decreases
in urinary pH and urinary citrate excretion. All these in-
crease the risk of forming large calcium-oxalate particles
[32]. All three effects derive from the fact that animal
protein constitutes an acid load for the body (Fig. 1)
[33]. Sulphur-containing amino acids (AA-SH) from
protein are converted in the liver, with protons and sul-
phate as by-products. Both plant- and animal-derived
protein constitutes an acid load. Similar reductions in
the risk of stone formation were found by preventing
an excess intake of animal protein or preventing an ex-
cess intake of plant protein [34]. However, plant protein
on average contains less AA-SH than animal protein,
and plant material also contains high concentrations
of organic acids. The latter constitute an alkali load
for the body, as they can be converted into bicarbonate
both in the liver and the kidney (Fig. 1). It is not the ex-
cess consumption of animal protein per se that poses a
problem, but the net acid load from the total diet and
the reaction of the body to that acid load.
A Western diet provides transient events of acid load-
ing when a high animal-protein intake is not balanced
by sources of organic acids. The acute effects of hyper-
calciuria, hypocitraturia and a low pH increase the risk
of stone formation. In the long term these acute effects
can accumulate and lead to bone loss. However, the
body has mechanisms to compensate for the effect of re-
nal calcium loss. When patients are accustomed to a
constant high animal-protein diet they show hypercalci-
uria which is not directly related to the acid load but
which can be reduced by a concomitant supply of alkali
(potassium citrate) [35]. An (insigniﬁcant) trend for
higher intestinal calcium can be sufﬁcient to explain that
the variables for bone turnover did not change. The
question is what will happen in the long term with pa-
tients who vary their dietary acid load from day-to-
day, a not uncommon situation. The same study showed
that serum parathyroid hormone (PTH) levels were
Figure 1 Why fruit juice (pH 2.8) is an alkali load and protein is
an acid load. 1 L of orange juice (pH 2.8) contains 1.5 mmol H+.
It also contains enough organic acids to produce 30 mmol HCO3
by conversion in both the liver and the kidney. 1 kg of meat causes
the production of 80 mmol H+ from conversion of AA-SH.
Adapted from [33].
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decreased by 10 pg/mL after 2 weeks of a high animal-
protein diet, while they were increased by 5 pg/mL after
2 weeks of a high animal-protein diet that was balanced
with potassium citrate. These changes were not signiﬁ-
cant, but were also found in another study [36], where
serum and urine composition was followed on an hourly
time scale after an acute load of animal protein. At the
ﬁrst time point, 1 h after the load, the serum PTH level
was clearly decreased. Serum PTH is regulated in re-
sponse to the serum free-calcium concentration. PTH
production decreases in response to hypercalcaemia.
As the half-life of PTH is 1 min, this leads to a de-
crease in serum PTH levels within minutes. Generally,
when a low serum PTH level is found the interpretation
is that there must have been a period of hypercalcaemia.
Thus in both studies the patients appear to have experi-
enced transient periods of hypercalcaemia in response to
a net acid load. In Fig. 2, I propose a mechanism that
might link acid-loading to hypercalciuria through tran-
sient hypercalcaemia. After consuming a protein load
(animal or plant) the liver starts to produce protons.
In the blood these protons are ﬁrst bound by blood buf-
fers. The level of blood buffers is, amongst other factors,
determined by the production of bicarbonate in the liver
and kidney. They produce bicarbonate from organic
acids like citrate and tartrate. Thus the net balance be-
tween protein and organic acids determines whether
the blood receives a net acid load, a neutral load or a
net alkali load. When the net acid load exceeds the buf-
fering capacity, blood pH decreases. The ﬁnding that
reducing a high animal-protein intake decreases the
stone formation rate, while further reducing normal ani-
mal protein intake does not [30,31] might be explained
by this threshold for the dietary net-acid load. When
the blood pH decreases unﬁlterable calcium that is
bound to albumin in the blood, it is released to the free
calcium pool, as that binding is pH-sensitive at around
pH 7.4 [37]. This extra free calcium passes to the renal
ﬁltration system and this is signalled by the parathyroid
glands, where it causes the unexplained decrease in PTH
production reported previously [35,36]. This decreases
intestinal calcium absorption and renal calcium
reabsorption. The extra ﬁltration at the glomerulus
and reduced distal reabsorption increase the calcium
concentration throughout the tubules. The decrease in
blood pH also elicits bicarbonate production by the li-
ver. If that is insufﬁcient, the kidneys reabsorb organic
acids like citrate from the proximal tubular ﬂuid, to con-
vert into bicarbonate. Reduced binding by citrate leaves
more calcium available in the tubular ﬂuid for combin-
ing with oxalate or phosphate. A low ﬂuid intake and
citrate also reduces the ability of the urine to inhibit
the formation of large calcium oxalate particles
[22,38,39]. After some time, addition of acid to the
blood will decrease, blood pH will increase and this will
be followed by a decrease in alkali production. Due to
the higher blood pH, albumin will bind more calcium
again, the serum free-calcium level will decrease and
transient slight hypocalcaemia can occur, as the PTH
level is still low and geared to reduce serum free-calcium
Figure 2 Cascade from acid-load to changes in urine composition. Adapted from [33].
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levels. PTH production increases and the body starts
to compensate for the calcium loss by increasing intesti-
nal uptake. After the whole ﬂuctuation has passed
(the time scale is unknown) the end result is urine with
a higher calcium content that seems to originate from
the intestine, a lower excretion of citrate, and a lower
pH.
This hypothesis has not been tested in all aspects and
it does not take into account that stone-formers more
often seem to have abnormalities in their renal acid han-
dling, e.g. incomplete renal tubular acidosis [40]. A high
prevalence of renal tubular acidosis might be involved,
in Thailand, in the endemic formation of LUT stones
also containing calcium oxalates in association with a
high prevalence of hypocitraturia [4–7]. However, it ex-
plains why an especially acute excess of animal protein is
a risk of urolithiasis and how this risk could best be re-
duced, i.e. by preventing acute events of high acid load-
ing. In practical terms, stone formers should be asked
not to eat too much meat, but when they do feel the urge
to consume a large portion, compensate that load with
enough fruits/vegetables or by alkali medication (potas-
sium citrate).
Water intake
A simple and very effective advice is to drink enough.
Drinking reduces the concentrations of the stone-form-
ing components and improves the removal of particles
from narrow parts of the urinary tract by increasing
the ﬂow rate [22]. Caveats can be that patients are not
aware of how much water they lose by sweating, and
that patients, upon the advice to drink more, should
not drink more high oxalate ﬂuids like tea. Again, if they
do want to drink tea, they should know that adding a
calcium source like milk lowers the risk posed by tea.
Medication and lifestyle advice for uric acid and urate
stone formation
The risk of uric acid and urate stone formation depends
both on urinary uric acid content and urinary pH. A
daily uric acid excretion of > 4 mmol, hyperuricosuria,
and a urinary pH continuously below 6.0 constitute in-
creased risks for uric acid stone formation. High urinary
uric acid levels can come from dietary over-consumption
of purines, alcohol and fructose; intrinsic factors, as
intrinsic overproduction in patients with speciﬁc enzyme
defects; from excessive breakdown of body tissue; and
from medication like probenecid. Uric acid excretion
can be reduced by reducing the intake of uric acid pre-
cursors and by medication that attacks uric acid produc-
tion, e.g. allopurinol. The lifestyle measures can be
prescribed to all uric-acid and urate stone formers. Allo-
purinol is reserved for patients who have both hyperur-
icosuria and hyperuricaemia, with a blood uric acid level
of > 380 lm.
Urinary pH determines how much urate is present in
the protonated, uric acid, form (low urinary pH) or de-
protonated, urate, form (high urinary pH). At pH 5.5,
50% of uric acid is present in the undissociated uric acid
form that forms uric acid stones. Above pH 6.5 urate
will dominate and can precipitate together with ammo-
nium if that is present in high quantities. In general,
the risk of forming a uric acid stone starts when the uri-
nary pH is constantly < 6.0 and it increases further with
decreasing urinary pH [41].
Thus uric-acid stone formers are also sensitive to an
acute dietary acid load. Furthermore, they are sensitive
to the chronic increase in renal acid load that accompa-
nies overweight [42], and the balance between renal
ammonium production and excretion of titratable acids
Table 2 Lifestyle advice for urolithiasis patients; adapted from [1].
Stone type Lifestyle advice/medication
Struvite Antibiotics against urease producing bacteria
Total stone removal
To remove fragments transient acidiﬁcation using L-methionine (200–500 mg, 3 times daily) to obtain a urine
pH between 5.8 and 6.2 can be applied
Drinking advice during the period of stone/fragment removal
Calcium oxalates/
calcium phosphates
Uric acid
Ammonium urate
Drinking advice, to reach a urine volume of > 2 litre a ﬂuid intake of > 2.5 litre is needed. For children the
advice is > 1.5 l/m2 body surface area. Drinking should be distributed over the day with some concentration
around food intake
Extra ﬂuid is needed to compensate sweat loss in a hot environment and during intensive physical activity
Normal calcium intake, 1000–1200 mg/day except for patients with proven absorptive hypercalciuria (urine
Ca > 8 mmol/day on average calcium intake and without ongoing bone loss)
Limited NaCl intake, 4–5 g/day unless excessive sweat loss calls for extra NaCl intake
Avoid excess animal protein (>1 g/kg/day). When a high animal protein intake does occur try to compensate
this with extra fruit/vegetables
Enough fruits and vegetables to maintain a neutral to slightly alkaline acid/base balance
Try to obtain the recommended daily allowances for vitamins and minerals from the diet. Added vitamin/
mineral can be applied but excess intake should be avoided
Minimise intake of food items with a high oxalate content
Strive for a BMI between 18 and 25 for adults. For children reduce overweight with respect to their age
group. This advice is especially important for patients who form urate/uric acid containing stones
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[43]. Each human cell produces some acid everyday.
Consequently, intrinsic acid production increases with
increasing body weight [42].
The contribution of intrinsic acid production is most
apparent in the morning urine; the dietary component
dominates for the rest of the day. Idiopathic uric-acid
stone formers produce more acid directly after a given
dietary load [44]. It is not clear if the total production
is higher, or that other people take more time to clear
the acid load to the urine. Irrespective of the mechanism,
urinary pH will be lower in idiopathic uric-acid stone
formers. Uric-acid stone formers should be advised to
maintain a balance between acid (protein) and alkali
load (organic acids from fruits and vegetables) or
optionally to receive alkali medication. Again, patients
will beneﬁt from lifestyle-analysis tools.
With increasing pH the urate form will dominate and
urate salts might precipitate. This will happen when the
counter-ion is also present in large enough quantities.
Thus patients who combine a high uric acid production
with a high pH and high urinary ammonium concentra-
tion are at risk of forming ammonium-urate stones.
Infection with urease-producing bacteria is the most
likely reason for this, and antibiotics are the treatment
of choice.
Role of obesity in calcium-salt and uric-acid stone
formation
Obese people have a higher risk of urolithiasis [45]. As
obesity affects over 300 million people worldwide [25]
it contributes considerably to worldwide stone forma-
tion. In the USA obesity might have reached its maxi-
mum prevalence [46,47]. In countries that more
recently have adopted a lifestyle leading to obesity, the
prevalence could continue to rise in the future. The in-
creased risk of stone formation in obese people is asso-
ciated with the lifestyle, an over-rich diet and too little
exercise, and the obesity itself (as explained above)
[48]. Of all stone formers, those with severe overweight
(>120 kg) have the highest daily urinary excretion rates
of calcium, oxalate and uric acid [49,50]. As urinary pH
is also inversely related to BMI [51], urinary super-satu-
ration with uric acid increases with increasing BMI, and
obesity is especially a risk for uric-acid stone formation
[52]. For calcium-oxalate stone formation the link is less
clear. Urinary super-saturation with calcium oxalate did
not increase with BMI [52], and neither was the preva-
lence of calcium-oxalate stone formation signiﬁcantly
higher in obese people. Still, a reduction of overweight
might be sensible advice to both types of stone formers,
as this automatically means adapting to the desired bal-
anced lifestyle and could provide extra motivation to
maintain that new lifestyle in the long term.
The high urinary calcium excretion in obese people is
largely due to the high intake of salt and animal protein.
From the mechanism proposed in Fig. 2 it would follow
that animal-protein intake will be a risk when it is not
balanced by alkali intake. Obese people who eat both
more animal protein and more vegetables and fruits
might have an extra incentive to gain weight but no ex-
tra risk of calcium loss. Of course, their body weight-re-
lated higher intrinsic acid production reduces the
tolerance for a dietary acid load. A more established
explanation is that the (especially abdominal) obesity
predisposes to insulin resistance [48]. This decreases
the renal ability to excrete an acid load as ammonium,
and induces renal consumption of organic acids like cit-
rate for bicarbonate production.
As changing someone’s lifestyle is difﬁcult, the surgi-
cal option to treat obesity, bariatric surgery, is becoming
increasingly popular. This approach is effective in treat-
ing obesity and several of its complications, but it also
increases the risk of especially calcium-oxalate stone for-
mation [26,27]. An object of the surgery is to reduce the
uptake of fatty acids. In the intestine these compete with
oxalate for binding calcium. When more fatty acids re-
main behind, more oxalate becomes available for up-
take. This explains the high urinary oxalate excretion
after bariatric surgery. Furthermore, the stool will be
soft or watery, inducing chronic bicarbonate loss, intra-
cellular metabolic acidosis, renal consumption of organ-
ic acids and hypocitraturia. The hyperoxaluria and
hypocitraturia are partly counteracted by a lower uri-
nary calcium excretion, but overall the drive for calcium
oxalate crystallisation is increased. Patients who have
had bariatric surgery should thus receive extra calcium
and extra alkali to compensate for these effects.
Consensus on medication and lifestyle advice to UUT
stone formers
For all patients who form stones containing calcium
salts and/or uric acid/urate, lifestyle advice is the pri-
mary approach to prevent recurrence. Medication
should be reserved for cases where lifestyle advice proves
insufﬁcient. This can be when there is an intrinsic prob-
lem, but also when patient compliance with lifestyle ad-
vice is low and remains low despite efforts to optimise it.
The drinking advice can be given to all stone formers.
When the stone type is known, more speciﬁc lifestyle ad-
vice and medication can be added. Tables 2 and 3 show
what type of lifestyle advice and medication can be pre-
scribed for which patients. For optimisation of the life-
style advice, both doctors and patients can use lifestyle-
analysing tools.
Optimisation of patient compliance
Lifestyle advice is a cornerstone for preventing urinary
stones and has conﬁrmed its potential [1]. Low patient
compliance greatly diminishes its effect. To obtain good
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compliance the patient must be well-informed about the
pros and cons of the lifestyle changes that are requested,
must be well motivated to start with the changes, and
must maintain a high motivation or make the new life-
style his or her own.
Information on lifestyle advice
Good information on lifestyle advice is available to
stone formers; in general practice this information is
delivered during the doctor/patient contacts and pro-
vided on paper for use at home. After reading the ﬁrst
three sections of this review, the advice summarised in
Table 2 might seem straightforward, but in practice
the patient at home can still be confused and needs addi-
tional individual advice. ‘The doctor told me to drink
more but also to be careful with tea. I only like tea.
What must I do?’. ‘I wouldn’t mind eating less salt but
how do I know how much salt I am eating?’. ‘I should
reduce my intake of animal protein but I really like to
eat meat’. ‘I have tried to be careful with eating oxa-
late-containing food and even tried to balance this with
my calcium intake, but I am not sure if I am doing OK’.
These are all the questions that can be answered when
there is precise knowledge about the diet, about the
composition of the items in the diet, and about the pos-
sible interactions (calcium oxalate, acid–base) as ex-
plained above. For these specialised answers the
average patient needs assistance from a doctor/dietician
or from interactive knowledge tools. In studies where
teams of doctors and dieticians provide such intensive
guidance, considerable reductions in stone formation
rate are achieved with lifestyle advice, i.e. [30]. In general
practice such guidance is not possible. To solve this
problem there are two routes that must be taken to-
gether. First is the use of ‘e-tools’ that provide contin-
uing information and motivation and have conﬁrmed
their worth in other diseases [53–55]. Patients with stone
need automated Internet tools that analyse the individ-
ual diet and provide individual advice, just as the team
doctor/dietician would do in the one-to-one situation.
Second, the attention of the doctor/dietician should be
concentrated into a ‘priming period’, after which the pa-
tient should have incorporated most of the advice into
their lifestyle. The ﬁrst steps in this direction are initia-
tives like the website www.niersteen.com that was devel-
oped for guiding patients in the Netherlands.
Continuing motivation
The starting motivation for patients who have just expe-
rienced colic pain is high. This motivation decreases as
the memory of the pain dissipates, and the hurdle to visit
the doctor increases. Providing enough attention during
that initial high-motivation period is crucial to obtaining
long-term high compliance. Especially important is that
the patients want feedback at the moment that they have
a question or a problem. In a large scale 2-year follow-
up study on exercise advice for women, those women
who received advice only at the start showed a signiﬁ-
cantly lower compliance than those where feedback
was given during frequent visits [56]. As noted, such in-
put from the doctor is not possible in general practice
and e-tools that can provide the guidance on a
(semi)automated basis will be of value. What needs to
be done in the near future is to test them for user-friend-
liness, ensure simple and safe access, and involve the pa-
tients themselves in further developments to ensure
optimal individualisation and thereby optimal long-term
compliance.
Table 3 When to use which medication.
Medication/dose Indication
Potassium citrate/
9–12 g/day
Sodium bicarbonate
1.5 g 3·/day
When adjustment of the acid/base towards the alkaline region is needed and dietary measures are not
suﬃcient. This can be the case for patients with high uric acid production, low dietary acid tolerance
(overweight, renal acidiﬁcation disorders), high intrinsic oxalate production. Stone types: uric acid, calcium-
oxalates, ammonium urate
Hydrochlorothiazide
25–50 mg/day
To correct hypercalciuria when that cannot be corrected by dietary advice (or by surgery in the case of
primary hyperparathyroidism)
Stone types: calcium-salts
Magnesium salts
200–400 mg/day
For patients with oxalate overproduction (hyperoxaluria that cannot be corrected by dietary advice).
Magnesium salts should not be given to patients with renal insuﬃciency
Stone types: calcium oxalates
Pyridoxine
5–20 mg/kg/day
Patients in whom hyperoxaluria remains present despite dietary restriction of oxalate and normalisation of
calcium intake (primary hyperoxaluria)
Goal: normo-oxaluria
L-Methionine
200–500 mg
3· daily
When acidiﬁcation of the urine is needed. This can be to remove fragments of infection stones (struvite/
calcium apatites) or patients with uric acid/ammonium urate stones
Goal: urinary pH 5.8–6.2, where urine pH remains >6.2 despite advice to neutralise the dietary acid/base
intake
Allopurinol
100–300 mg/day
For patients with hyperuricosuria that is not corrected by dietary advice. These are patients who produce
extra uric acid as a result of severe overweight or due to an enzymatic disorder. The high dose should be
reserved for patients who have both hyperuricosuria and hyperuricosaemia
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